Question 1

Is Laxisam Pharmaceuticals GMP certified?

Accepted Answer

Yes. In April 2024 the company received national GMP certificate No. GMP-08:2024, confirming that its manufacturing processes comply with international standards. The certificate is valid until April 2027.

Question 2

What dosage forms does Laxisam manufacture?

Accepted Answer

Ampoules for injection (2 ml, 5 ml, 10 ml), tablets, capsules and sachets. A new four-storey building of 6,750 m² is under construction for suppositories, syrups and ointments.

Question 3

What is the production capacity?

Accepted Answer

Up to 24,000 ampoules per hour, which is 14.2 million ampoules per year in single-shift mode; a tablet press at 80,000 tablets per hour; a capsule filling machine at 50,000 capsules per hour; and 14.8 million blister packs per year.

Question 4

Where is the plant located?

Accepted Answer

Tashkent, Olmazor district, Usta Shirin street 254A, Republic of Uzbekistan. Production area is 11,800 m² on a plot of 0.67 hectares.

Question 5

Does Laxisam offer contract manufacturing for other companies?

Accepted Answer

The company manufactures pharmaceutical products in Uzbekistan and works with partners holding marketing authorisations. Enquiries are handled by phone +998 71 228-14-24 or by email office@laxisampharmaceuticals.ru.

Question 6

Which markets does the company supply?

Accepted Answer

Uzbekistan is the primary market; the company also supplies CIS and Central Asian countries, including Kazakhstan, Kyrgyzstan, Tajikistan and Turkmenistan.